Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Jan-Dec:23:15347354231223496.
doi: 10.1177/15347354231223496.

A Prospective Multi-Centered Registry-Based Observational Study for Patients With Cancer: Design and Rationale for Korean Medicine Cancer Registry (KMCARE)

Affiliations
Observational Study

A Prospective Multi-Centered Registry-Based Observational Study for Patients With Cancer: Design and Rationale for Korean Medicine Cancer Registry (KMCARE)

Jee Young Lee et al. Integr Cancer Ther. 2024 Jan-Dec.

Abstract

Background: Cancer is one of the leading causes of death in most countries with an expected increased burden on healthcare systems. Since integrative medical treatments are not collected within the scope of existing cancer registries, the establishment of the Korean Medicine Cancer Registry (KMCARE), gathering integrative therapies, including conservative care and Korean medicine, is warranted.

Methods: A prospective observational study based on the registry will be conducted in 5 Korean medical hospitals. A total of 650 eligible participants undergoing Korean medicine treatments within 1 month of a diagnosis of lung, colorectal, stomach, or breast cancer are anticipated to be enrolled in the registry. Data collected in the KMCARE can be classified into patient information, received treatments, and outcomes. The primary outcome is the Functional Assessment of Cancer Therapy-General Questionnaire score at 3 months. Secondary outcomes include the MD Anderson Symptom Inventory-Core and the Body Constitution Questionnaire at 3 and 6 months. After 6 months of follow-up periods, survival surveillance will be continued for additional 18 months. Descriptive and statistical analysis of primary and secondary outcomes, baseline data, safety, survival, and prognostic factors will be performed.

Discussion: This is the first prospective, multi-centered, registry-based observational study of cancer patients in Korean medicine hospitals, which could reveal the current status of cancer patients receiving integrative cancer therapies, and provide better insight into the role of Korean medicine in palliative care for patients with cancer.

Trial registration: Clinical Research Information Service (CRIS), KCT0007447.

Keywords: Korean medicine; Registry; cancer; nationwide observational study; palliative care.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Korea Central Cancer Registry, National Cancer Center. Annual Report of Cancer Statistics in Korea in 2020. Ministry of Health and Welfare; 2023. Accessed August 8, 2023. https://ncc.re.kr/cancerStatsList.ncc?searchKey=total&searchValue=&pageN...
    1. Kaasa S, Loge JH, Aapro M, et al. Integration of oncology and palliative care: a Lancet Oncology Commission. Lancet Oncol. 2018;19:e588-e653. doi: 10.1016/S1470-2045(18)30415-7 - DOI - PubMed
    1. Roth AR, Canedo AR. Introduction to hospice and palliative care. Prim Care. 2019;46:287-302. doi: 10.1016/j.pop.2019.04.001 - DOI - PubMed
    1. Sheikh IN, Miller J, Shoberu B, et al. Using the MDASI-adolescent for early symptom identification and mitigation of symptom impact on daily living in adolescent and young adult stem cell transplant patients. Children. 2021;9:19. doi: 10.3390/children9010019 - DOI - PMC - PubMed
    1. Ferrari M, Ripamonti CI, Hulbert-Williams NJ, Miccinesi G. Relationships among unmet needs, depression, and anxiety in non-advanced cancer patients. Tumori. 2019;105:144-150. doi: 10.1177/0300891618765546 - DOI - PubMed

Publication types